• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.胃上皮样炎性肌纤维母细胞肉瘤:诊断陷阱与临床特征
Int J Clin Exp Pathol. 2019 May 1;12(5):1738-1744. eCollection 2019.
2
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.上皮样炎性肌纤维母细胞肉瘤:一种具有核膜或核周 ALK 的侵袭性腹腔内炎性肌纤维母细胞瘤变体。
Am J Surg Pathol. 2011 Jan;35(1):135-44. doi: 10.1097/PAS.0b013e318200cfd5.
3
Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.在上皮样炎性肌纤维母细胞肉瘤中鉴定EML4-ALK作为一种替代性融合基因。
Orphanet J Rare Dis. 2017 May 23;12(1):97. doi: 10.1186/s13023-017-0647-8.
4
Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.具有侵袭性行为的子宫炎性肌纤维母细胞瘤,包括上皮样炎性肌纤维母细胞肉瘤:9 例临床病理研究。
Am J Surg Pathol. 2022 Jan 1;46(1):105-117. doi: 10.1097/PAS.0000000000001756.
5
Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.上皮样炎性肌纤维母细胞肉瘤:5例新增病例的临床病理、免疫组化及分子细胞遗传学分析并文献复习
Diagn Pathol. 2016 Jul 27;11(1):67. doi: 10.1186/s13000-016-0517-z.
6
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.病例报告:用ALK酪氨酸激酶抑制剂恩沙替尼治疗上皮样炎性肌纤维母细胞肉瘤。
Front Oncol. 2023 Mar 22;13:1084456. doi: 10.3389/fonc.2023.1084456. eCollection 2023.
7
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.非典型炎性肌纤维母细胞瘤中的ALK癌蛋白:上皮样炎性肌纤维母细胞肉瘤中的新型RRBP1-ALK融合基因
J Pathol. 2017 Feb;241(3):316-323. doi: 10.1002/path.4836. Epub 2016 Dec 15.
8
Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.携带RANBP2-ALK融合基因的原发性皮肤上皮样炎性肌纤维母细胞肉瘤:1例罕见病例报告
Am J Dermatopathol. 2022 Apr 1;44(4):302-305. doi: 10.1097/DAD.0000000000002096.
9
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring Rearrangement: A Case Report.携带重排的上皮样炎性肌纤维母细胞肉瘤对ALK酪氨酸激酶抑制剂的持久临床反应:一例报告
Front Oncol. 2022 Feb 14;12:761558. doi: 10.3389/fonc.2022.761558. eCollection 2022.
10
Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.上皮样炎性肌纤维母细胞肉瘤的临床病理分析
Oncol Lett. 2018 Jun;15(6):9317-9326. doi: 10.3892/ol.2018.8530. Epub 2018 Apr 18.

引用本文的文献

1
Rare giant epithelioid inflammatory myofibroblastic sarcoma of the abdominal cavity in a child: a case report and review of the literature.儿童腹腔罕见的巨大上皮样炎性肌成纤维细胞肉瘤:一例报告并文献复习
Front Oncol. 2024 Dec 5;14:1417918. doi: 10.3389/fonc.2024.1417918. eCollection 2024.
2
Epithelioid inflammatory myofibroblastic sarcoma treated with Alectinib: a case report and literature review.阿来替尼治疗上皮样炎性肌纤维母细胞肉瘤:一例报告及文献综述
Front Oncol. 2024 Aug 30;14:1412225. doi: 10.3389/fonc.2024.1412225. eCollection 2024.
3
Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report.对克唑替尼反应不佳的上皮样炎性肌纤维母细胞肉瘤:一例报告
Clin Med Insights Case Rep. 2023 Oct 12;16:11795476231163954. doi: 10.1177/11795476231163954. eCollection 2023.
4
Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review.上皮样炎性肌纤维母细胞肉瘤:1例报告并文献复习
Front Oncol. 2023 Sep 29;13:1212529. doi: 10.3389/fonc.2023.1212529. eCollection 2023.
5
Epithelioid Inflammatory Myofibroblastic Sarcoma Presenting as Gastrointestinal Bleed: Case Report and Literature Review.以胃肠道出血为表现的上皮样炎性肌纤维母细胞肉瘤:病例报告及文献复习
JPGN Rep. 2020 Dec 17;2(1):e019. doi: 10.1097/PG9.0000000000000019. eCollection 2021 Feb.
6
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.病例报告:用ALK酪氨酸激酶抑制剂恩沙替尼治疗上皮样炎性肌纤维母细胞肉瘤。
Front Oncol. 2023 Mar 22;13:1084456. doi: 10.3389/fonc.2023.1084456. eCollection 2023.
7
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis.恶性外周神经鞘膜瘤细胞系的深度基因组分析对当前恶性外周神经鞘膜瘤的诊断提出了挑战。
iScience. 2023 Jan 31;26(2):106096. doi: 10.1016/j.isci.2023.106096. eCollection 2023 Feb 17.
8
Inflammatory Myofibroblastic Tumour: State of the Art.炎性肌纤维母细胞瘤:最新进展
Cancers (Basel). 2022 Jul 27;14(15):3662. doi: 10.3390/cancers14153662.
9
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.原发性肺上皮样炎性肌纤维母细胞肉瘤:一种罕见疾病及文献综述
J Pathol Transl Med. 2022 Jul;56(4):231-237. doi: 10.4132/jptm.2022.05.08. Epub 2022 Jul 7.
10
Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.中枢神经系统伴有VCL-ALK融合的上皮样炎性肌纤维母细胞肉瘤:病例报告及文献简要回顾
Brain Tumor Pathol. 2022 Jan;39(1):35-42. doi: 10.1007/s10014-021-00416-z. Epub 2021 Nov 6.

本文引用的文献

1
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer.用于治疗晚期尿路上皮膀胱癌的PD1/PDL1抑制剂。
Onco Targets Ther. 2018 Sep 19;11:5973-5989. doi: 10.2147/OTT.S135157. eCollection 2018.
2
Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.上皮样炎性肌纤维母细胞肉瘤的临床病理分析
Oncol Lett. 2018 Jun;15(6):9317-9326. doi: 10.3892/ol.2018.8530. Epub 2018 Apr 18.
3
Epithelioid Inflammatory Myofibroblastic Sarcoma.上皮样炎性肌纤维母细胞肉瘤
Int J Surg Pathol. 2019 Feb;27(1):69-71. doi: 10.1177/1066896918767557. Epub 2018 Apr 6.
4
Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.伴有RANB2-ALK融合的卵巢上皮样炎性肌纤维母细胞肉瘤:一例报告
Int J Gynecol Pathol. 2018 Sep;37(5):468-472. doi: 10.1097/PGP.0000000000000431.
5
Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.在上皮样炎性肌纤维母细胞肉瘤中鉴定EML4-ALK作为一种替代性融合基因。
Orphanet J Rare Dis. 2017 May 23;12(1):97. doi: 10.1186/s13023-017-0647-8.
6
PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data.程序性死亡配体1(PD-L1)表达作为晚期非小细胞肺癌的预测生物标志物:更新的生存数据
Immunotherapy. 2017 May;9(6):499-506. doi: 10.2217/imt-2016-0150.
7
Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center.18例炎症性肌纤维母细胞瘤的临床病理研究及ALK-1表达分析:三级医疗中心的5年经验
J Pathol Transl Med. 2017 May;51(3):255-263. doi: 10.4132/jptm.2017.01.12. Epub 2017 Apr 17.
8
[Epithelioid inflammatory myofibroblastic sarcoma of small bowel mesentery: report of a case].[小肠系膜上皮样炎性肌成纤维细胞肉瘤:一例报告]
Zhonghua Bing Li Xue Za Zhi. 2017 Mar 8;46(3):201-202. doi: 10.3760/cma.j.issn.0529-5807.2017.03.014.
9
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.非典型炎性肌纤维母细胞瘤中的ALK癌蛋白:上皮样炎性肌纤维母细胞肉瘤中的新型RRBP1-ALK融合基因
J Pathol. 2017 Feb;241(3):316-323. doi: 10.1002/path.4836. Epub 2016 Dec 15.
10
Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.上皮样炎性肌纤维母细胞肉瘤:5例新增病例的临床病理、免疫组化及分子细胞遗传学分析并文献复习
Diagn Pathol. 2016 Jul 27;11(1):67. doi: 10.1186/s13000-016-0517-z.

胃上皮样炎性肌纤维母细胞肉瘤:诊断陷阱与临床特征

Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.

作者信息

Xu Pei, Shen Pingping, Jin Yangli, Wang Li, Wu Weiwei

机构信息

Department of Burns, Ningbo Huamei Hospital, University of Chinese Academy of Science (Ningbo No. 2 Hospital) Ningbo, China.

Department of Gastroenterology, Yinzhou Second Hospital Ningbo, China.

出版信息

Int J Clin Exp Pathol. 2019 May 1;12(5):1738-1744. eCollection 2019.

PMID:31933992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6947137/
Abstract

Inflammatory myofibroblastic tumor (IMT) is a neoplasm composed of spindled neoplastic myofibroblasts admixed with reactive lymphoplasmacytic cells, plasma cells, and/or eosinophils, which has an intermediate biological behavior. An IMT variant with plump round epithelioid or histiocytoid tumor cells, recognized as epithelioid inflammatory myofibroblastic sarcoma (EIMS), has a more clinically aggressive progression. To the best of our knowledge, only about 40 cases of EIMS have previously been reported in limited literature. Here, we report here a case of unusual EIMS with a relative indolent clinical behavior. We reviewed the literature for 18 similar cases. The patients present with a highly aggressive inflammatory myofibroblastic tumor characterized by round or epithelioid morphology, prominent neutrophilic infiltrate, and positive staining of ALK with RANBP2-ALK gene fusion or RANBP1-ALK gene fusion, or EML4-ALK gene fusion. Our case is the first case of primary stomach EIMS. Moreover, the mechanisms of the rare entity have not been widely recognized and require further study. Early accurate diagnosis and complete resection of this tumor is necessary. Some researchers suggest expression of PD-L1 may provide new strategies for ALK-targeted therapy.

摘要

炎性肌纤维母细胞瘤(IMT)是一种由梭形肿瘤性肌成纤维细胞与反应性淋巴细胞、浆细胞和/或嗜酸性粒细胞混合组成的肿瘤,具有中间型生物学行为。一种具有丰满圆形上皮样或组织细胞样肿瘤细胞的IMT变异型,被认为是上皮样炎性肌纤维母细胞肉瘤(EIMS),其临床进展更具侵袭性。据我们所知,此前在有限的文献中仅报道了约40例EIMS。在此,我们报告一例具有相对惰性临床行为的罕见EIMS病例。我们回顾了文献中的18例类似病例。这些患者表现为一种高度侵袭性的炎性肌纤维母细胞瘤,其特征为圆形或上皮样形态、显著的中性粒细胞浸润,以及ALK染色阳性伴RANBP2-ALK基因融合或RANBP1-ALK基因融合,或EML4-ALK基因融合。我们的病例是原发性胃EIMS的首例。此外,这种罕见实体的发病机制尚未得到广泛认识,需要进一步研究。早期准确诊断并完整切除该肿瘤是必要的。一些研究人员认为,PD-L1的表达可能为ALK靶向治疗提供新策略。